DISEASE ACTIVITY, STERIOD-FREE REMISSION, AND CLINICAL OUTCOME ASSESSMENTS OF PEDIATRIC ULCERATIVE COLITIS AND CROHN’S DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY